Clinical Trials List
2017-11-01 - 2025-02-05
Phase II/III
Terminated10
-
Trial Applicant
ICON Clinical Research Pte Ltd
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ya-Ping Chen Division of General Internal Medicine
- Ya-Ting Hsu Division of General Internal Medicine
- Sin-Syue Li Division of General Internal Medicine
- Wei-Pang Chung Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- YU-HSUAN SHIH Division of Hematology & Oncology
- 滕傑林 Division of Hematology & Oncology
- Chieh-Lin Teng Division of Hematology & Oncology
- HSIN-CHEN LIN Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ming-Chung Kao Division of Hematology & Oncology
- Tung-Liang Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- HUI-WEN LIU Division of Hematology & Oncology
- TSU-YI CHAO Division of General Internal Medicine
- Wei-Hong Cheng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ching-Chan Lin Division of Hematology & Oncology
- Su-Peng Yeh Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
- Tzu-Ting Chen
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jyh-Pyng Gau Division of General Internal Medicine
- Po-Shen Ko Division of General Internal Medicine
- Hao-Yuan Wang Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
450 participants
